Should I buy or sell Paragon 28 stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Paragon 28 in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FNA shares. View FNA analyst ratings or view top-rated stocks .

What is Paragon 28's stock price target for 2024?

4 brokerages have issued 12-month price objectives for Paragon 28's shares. Their FNA share price targets range from $17.00 to $18.00. On average, they anticipate the company's stock price to reach $17.67 in the next twelve months. This suggests a possible upside of 83.1% from the stock's current price. View analysts price targets for FNA or view top-rated stocks among Wall Street analysts .

How have FNA shares performed in 2024?

Paragon 28's stock was trading at $12.43 at the beginning of 2024. Since then, FNA stock has decreased by 22.4% and is now trading at $9.65. View the best growth stocks for 2024 here .

Are investors shorting Paragon 28?

Paragon 28 saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 2,430,000 shares, an increase of 30.6% from the March 15th total of 1,860,000 shares. Based on an average daily trading volume, of 538,400 shares, the short-interest ratio is currently 4.5 days. Currently, 6.7% of the shares of the company are short sold. View Paragon 28's Short Interest .

When is Paragon 28's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our FNA earnings forecast .

How were Paragon 28's earnings last quarter?

Paragon 28, Inc. (NYSE:FNA) announced its quarterly earnings data on Thursday, February, 29th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.09. The business earned $60.56 million during the quarter, compared to analysts' expectations of $60.73 million. Paragon 28 had a negative net margin of 22.11% and a negative trailing twelve-month return on equity of 22.51%.

What guidance has Paragon 28 issued on next quarter's earnings?

Paragon 28 updated its FY 2024 earnings guidance on Friday, April, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $249.0 million-$259.0 million, compared to the consensus revenue estimate of $253.9 million.

When did Paragon 28 IPO?

Paragon 28 (FNA) raised $125 million in an initial public offering on Friday, October 15th 2021. The company issued 7,800,000 shares at $15.00-$17.00 per share. BofA Securities and Piper Sandler acted as the underwriters for the IPO and Canaccord Genuity, JMP Securities and Needham & Company were co-managers.

How do I buy shares of Paragon 28?

Shares of FNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:FNA

Paragon 28 (FNA) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free FNA Stock Alerts

$9.65

-0.08 (-0.82%)

(As of 04/18/2024 ET)

Compare

Today's Range: $9.60
▼
$9.94
50-Day Range: $8.87
▼
$14.55
52-Week Range: $7.95
▼
$19.72

Volume: 345,720 shs
Average Volume: 629,662 shs
Market Capitalization: $800.08 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $17.67

Get Paragon 28 alerts:

Paragon 28 MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 83.1% Upside
$17.67 Price Target
Short Interest: Bearish
6.67% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.02
Based on 7 Articles This Week
Insider Trading: Acquiring Shares
$255,360 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($0.43) to ($0.33) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.57 out of 5 stars

Medical Sector

442nd out of 918 stocks

Surgical & Medical Instruments Industry

48th out of 95 stocks

3.5

Analyst's Opinion

Consensus Rating
Paragon 28 has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Paragon 28 has only been the subject of 3 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
6.67% of the float of Paragon 28 has been sold short.
Short Interest Ratio / Days to Cover
Paragon 28 has a short interest ratio ("days to cover") of 4.5.
Change versus previous month
Short interest in Paragon 28 has recently increased by 30.65%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Paragon 28 does not currently pay a dividend.
Dividend Growth
Paragon 28 does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for FNA.

2.8

News and Social Media Coverage

News Sentiment
Paragon 28 has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Paragon 28 this week, compared to 2 articles on an average week.
Search Interest
Only 2 people have searched for FNA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Paragon 28 to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Paragon 28 insiders have bought more of their company's stock than they have sold. Specifically, they have bought $255,360.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
15.32% of the stock of Paragon 28 is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
63.57% of the stock of Paragon 28 is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Paragon 28 are expected to grow in the coming year, from ($0.43) to ($0.33) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Paragon 28 is -16.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Paragon 28 is -16.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Paragon 28 has a P/B Ratio of 4.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Paragon 28 Stock (NYSE:FNA)

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

FNA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FNA Stock News Headlines

March 19, 2024 | insidertrades.com

Insider Buying: Paragon 28, Inc. (NYSE:FNA) Insider Acquires 28,000 Shares of Stock

April 15, 2024 | americanbankingnews.com

Paragon 28, Inc. (NYSE:FNA) Short Interest Up 30.6% in March

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 12, 2024 | finance.yahoo.com

Paragon 28, Inc. (NYSE:FNA) has caught the attention of institutional investors who hold a sizeable 36% stake

April 5, 2024 | markets.businessinsider.com

Analysts Are Bullish on Top Healthcare Stocks: Paragon 28 (FNA), Caribou Biosciences (CRBU)

April 4, 2024 | benzinga.com

Unveiling 4 Analyst Insights On Paragon 28

April 4, 2024 | markets.businessinsider.com

Paragon 28 CFO Stephen Deitsch Resigns; Names Interim Replacement; Backs Annual Revenue Outlook

April 4, 2024 | globenewswire.com

Appointment of Stephen M. Deitsch as new Chief Financial Officer

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 4, 2024 | marketwatch.com

Paragon 28 Chief Financial Officer Stephen Deitsch Resigns

April 4, 2024 | businesswire.com

NeuroStreet To Transform Trading Technology With Tickblaze Acquisition

April 4, 2024 | businesswire.com

Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024

March 29, 2024 | markets.businessinsider.com

Buy Rating Affirmed for Paragon 28 on Strategic Product Launches and Strong Market Position

March 28, 2024 | stockhouse.com

Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE(TM) Extraosseous Repair System

March 28, 2024 | businesswire.com

Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System

March 28, 2024 | businesswire.com

Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System

March 28, 2024 | markets.businessinsider.com

Piper Sandler Keeps Their Buy Rating on Paragon 28 (FNA)

March 2, 2024 | markets.businessinsider.com

Buy Rating Affirmed: Paragon 28’s Strong Q4 Performance and Promising 2024 Prospects

March 2, 2024 | markets.businessinsider.com

Buy Rating Affirmed: Paragon 28’s Strong Growth Prospects and Innovative Pipeline

March 2, 2024 | finance.yahoo.com

Paragon 28 Full Year 2023 Earnings: EPS Misses Expectations

March 2, 2024 | finance.yahoo.com

Paragon 28, Inc. (NYSE:FNA) Q4 2023 Earnings Call Transcript

March 1, 2024 | markets.businessinsider.com

Analysts Conflicted on These Healthcare Names: Paragon 28 (FNA) and Cooper Co (COO)

March 1, 2024 | finance.yahoo.com

Q4 2023 Paragon 28 Inc Earnings Call

February 29, 2024 | seekingalpha.com

Paragon 28, Inc. 2023 Q4 - Results - Earnings Call Presentation

February 29, 2024 | benzinga.com

Recap: Paragon 28 Q4 Earnings

February 29, 2024 | finance.yahoo.com

Paragon 28 Inc (FNA) Reports Growth and Sets Positive Outlook for 2024

February 29, 2024 | businesswire.com

Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance

See More Headlines

Receive FNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Paragon 28 and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/29/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NYSE:FNA
CUSIP: N/A
CIK: 1531978
Web: www.paragon28.com
Phone: 720-912-1332
Fax: N/A
Employees: 574
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $17.67
High Stock Price Target: $18.00
Low Stock Price Target: $17.00
Potential Upside/Downside: +83.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.58)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-47,840,000.00
Net Margins: -22.11%
Pretax Margin: -22.01%
Return on Equity: -22.51%
Return on Assets: -13.98%

Debt

Debt-to-Equity Ratio: 0.62
Current Ratio: 4.21
Quick Ratio: 2.30

Sales & Book Value

Annual Sales: $216.39 million
Price / Sales: 3.70
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.15 per share
Price / Book: 4.49

Miscellaneous

Outstanding Shares: 82,910,000
Free Float: 70,205,000
Market Cap: $800.08 million
Optionable: Optionable
Beta: 1.01

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Albert DaCosta (Age 50)
Co-Founder, Chairman, President & CEO
Comp: $1.55M
Mr. Stephen M. Deitsch (Age 52)
Chief Financial Officer
Comp: $826.32k
Mr. Matthew Jarboe (Age 40)
Chief Commercial Officer
Comp: $985.39k
Mr. Jeff Sears
Vice President of Operations
Mr. Erik E Mickelson (Age 41)
Chief Accounting Officer & Controller
Matt Brinckman
Senior Vice President of Strategy & Investor Relations
Ms. Michelle Missal
VP & Chief Compliance Officer
Mr. Jonathan L. Friedman (Age 53)
General Counsel & Secretary
Mr. John Shumaker
Executive Vice President of Sales - U.S.
Mr. Brendan Shook
Executive VP of Marketing & Medical Education

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

FNA Stock Analysis - Frequently Asked Questions

Should I buy or sell Paragon 28 stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Paragon 28 in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FNA shares.
View FNA analyst ratings or view top-rated stocks.
What is Paragon 28's stock price target for 2024?: 4 brokerages have issued 12-month price objectives for Paragon 28's shares. Their FNA share price targets range from $17.00 to $18.00. On average, they anticipate the company's stock price to reach $17.67 in the next twelve months. This suggests a possible upside of 83.1% from the stock's current price.
View analysts price targets for FNA or view top-rated stocks among Wall Street analysts.
How have FNA shares performed in 2024?: Paragon 28's stock was trading at $12.43 at the beginning of 2024. Since then, FNA stock has decreased by 22.4% and is now trading at $9.65.
View the best growth stocks for 2024 here.
Are investors shorting Paragon 28?: Paragon 28 saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 2,430,000 shares, an increase of 30.6% from the March 15th total of 1,860,000 shares. Based on an average daily trading volume, of 538,400 shares, the short-interest ratio is currently 4.5 days. Currently, 6.7% of the shares of the company are short sold.
View Paragon 28's Short Interest.
When is Paragon 28's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our FNA earnings forecast.

How were Paragon 28's earnings last quarter?: Paragon 28, Inc. (NYSE:FNA) announced its quarterly earnings data on Thursday, February, 29th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.09. The business earned $60.56 million during the quarter, compared to analysts' expectations of $60.73 million. Paragon 28 had a negative net margin of 22.11% and a negative trailing twelve-month return on equity of 22.51%.
What guidance has Paragon 28 issued on next quarter's earnings?: Paragon 28 updated its FY 2024 earnings guidance on Friday, April, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $249.0 million-$259.0 million, compared to the consensus revenue estimate of $253.9 million.
When did Paragon 28 IPO?: Paragon 28 (FNA) raised $125 million in an initial public offering on Friday, October 15th 2021. The company issued 7,800,000 shares at $15.00-$17.00 per share. BofA Securities and Piper Sandler acted as the underwriters for the IPO and Canaccord Genuity, JMP Securities and Needham & Company were co-managers.
How do I buy shares of Paragon 28?: Shares of FNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:FNA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial